Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Y Yu

Showing results (1-10 of 234) with videos related to

Pageof 24
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual MeetingEvan Y Yu
Nature Reviews. Urology|December 12, 2012
Prostate cancer: Bone density testing--essential or extraneous?Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2025
Drug Targets in Prostate Cancer: An Appetite for KLK2-Mediated DestructionSteven Blinka, Evan Y Yu
Current Treatment Options in Oncology|June 30, 2019
Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of ImmunotherapyPetros Grivas, Evan Y Yu
Current Opinion in Urology|January 25, 2013
Castrate-resistant prostate cancer: postdocetaxel managementSong Zhao, Evan Y Yu
JAMA Oncology|July 17, 2015
Progress in Understanding What Is Being Statin(ed) in Prostate CancerJorge D Ramos, Evan Y Yu
Asian Journal of Andrology|April 25, 2014
The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questionsEvan Y Yu, William K Oh
Clinical Prostate Cancer|May 11, 2005
Genetic alterations in prostate cancerEvan Y Yu, William C Hahn
Oncology (Williston Park, N.Y.)|August 28, 2013
Targeted therapy in the treatment of castration-resistant prostate cancerChristina L Derleth, Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2020
"Matching" the "Mismatch" Repair-Deficient Prostate Cancer with ImmunotherapyMichael T Schweizer, Evan Y Yu
Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:
Pageof 24
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Highlights in prostate cancer from the 2011 American Urological Association Annual Meeting and the 2011 American Society of Clinical Oncology Annual MeetingEvan Y Yu
Nature Reviews. Urology|December 12, 2012
Prostate cancer: Bone density testing--essential or extraneous?Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2025
Drug Targets in Prostate Cancer: An Appetite for KLK2-Mediated DestructionSteven Blinka, Evan Y Yu
Current Treatment Options in Oncology|June 30, 2019
Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of ImmunotherapyPetros Grivas, Evan Y Yu
Current Opinion in Urology|January 25, 2013
Castrate-resistant prostate cancer: postdocetaxel managementSong Zhao, Evan Y Yu
JAMA Oncology|July 17, 2015
Progress in Understanding What Is Being Statin(ed) in Prostate CancerJorge D Ramos, Evan Y Yu
Asian Journal of Andrology|April 25, 2014
The metastatic castration-resistant prostate cancer treatment paradigm: more choices, more questionsEvan Y Yu, William K Oh
Clinical Prostate Cancer|May 11, 2005
Genetic alterations in prostate cancerEvan Y Yu, William C Hahn
Oncology (Williston Park, N.Y.)|August 28, 2013
Targeted therapy in the treatment of castration-resistant prostate cancerChristina L Derleth, Evan Y Yu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2020
"Matching" the "Mismatch" Repair-Deficient Prostate Cancer with ImmunotherapyMichael T Schweizer, Evan Y Yu
Pageof 24